Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study.
第一作者:
Ilaria,Rizzello
第一单位:
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.;Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
作者:
医学主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);地塞米松(Dexamethasone);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);多发性骨髓瘤(Multiple Myeloma);回顾性研究(Retrospective Studies);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome)
DOI
10.1080/10428194.2021.1897805
PMID
33733993
发布时间
2021-08-16
- 浏览2
Leukemia & lymphoma
1897-1906页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



